.
Recently, immune checkpoint inhibitors targeting PD-1 or PD-L1
were approved by the FDA to treat advanced melanoma (e.g., pembrolizumab). Approximately one-third of patients with advanced melanoma are responsive to PD-1 inhibitors. However, resistance to BRAF inhibitors is observed in a majority of the responsive patients. One mechanism accounting for the resistance is due to the aberrant upregulation of EGFR and downstream PI3K/Akt signaling . Twenty-five percent of the immune checkpoint inhibitor responsive tumors also recur despite continued treatment.
The mechanism of the resistance is still elusive although mutations in either JAK1 or JAK2 account for part of the resistance mechanism (Zaretsky et al., 2016) . Therefore, mechanistic study of melanomagenesis, especially for the tumors that are not responsive to existing therapy, is needed to develop new effective treatments.
Additionally, drug resistance observed in current melanoma therapy underscores the need for development of new therapeutic strategies that counteract therapy resistance and/or to target the disease through a different mechanism.
The Xiphophorus melanoma model, also known as "GordonKosswig-Anders" melanoma model, was originally introduced in the late 1920s, as one of the first animal models leading to genetic studies of cancer (Gordon, 1927; Häussler, 1928; Kosswig, 1928) .
This model employs X. maculatus and X. hellerii interspecies hybrids to produce spontaneous, yet genetically controlled, melanoma. In the classical cross X. maculatus carries the spotted dorsal (Sd) macromelanophore pigmentation pattern while X. hellerii does not have such a pigmentation pattern (For reviews, see: (Patton, Mathers, & Schartl, 2011; Walter & Kazianis, 2001) . Neither the Sd locus, nor a functional equivalent of the X. maculatus R(Diff) locus, a hypothetical tumor suppressor mapped to linkage group 5, is present in X. hellerii. The X-chromosome and Sd linked oncogene, xmrk, is a mutant copy of the fish orthologue of the human EGFR and have been established as a melanoma driver oncogene in transgenic studies (Schartl et al., 2010 . In contrast, the critical genetic component of the autosomal R(Diff) locus, which regulates xmrk, is still unknown. R(Diff) has been mapped to a 5.8-Mb region on linkage group 5 and is proposed to inhibit xmrk function in X. maculatus parental animals as they rarely develop melanoma tumors (Adam, Maueler, & Schartl, 1991; Kazianis et al., 1998 Kazianis et al., , 1999 Lu et al., 2017) . F 1 interspecies hybrids between X. maculatus and X. hellerii (i.e., Sd-hellerii) exhibit enhanced dorsal fin pigmentation but do not develop melanoma, likely due to regulation by the remaining single copy of the X. maculatus R(Diff) locus. When F 1 hybrids are backcrossed with X. hellerii, 25% of progeny that inherited the xmrk oncogene, but did not inherit the R(Diff) locus, develop spontaneous, lethal melanoma. Other model systems have been developed that take advantage of the xmrk driver oncogene, such as the xmrk transgenic medaka (Japanese rice fish, Oryzias latipes). In this transgenic model, xmrk is driven by pigment cell-specific mitf promoter, resulting in early onset melanoma development with 100% penetrance (Schartl et al., 2010 .
The xmrk oncogene is capable of inducing transformation in melanocytes by maintaining sustained MAPK signaling. Similar to dedifferentiated melanocytes induced by other oncogenes (i.e., bFGF, myc, Ela, ras, or neu) dedifferentiated cells show enhanced proliferation, absence of dendrites, and a lack of melanin production (Dotto, Moellmann, Ghosh, Edwards, & Halaban, 1989; Wellbrock, Fischer, & Schartl, 1998; Wellbrock, Weisser, Geissinger, Troppmair, & Schartl, 2002; Wilson, Dooley, & Hart, 1989) . The xmrk gene influences several EGFR regulated pathways that are consistent with published observations of mammalian melanomas that drive and maintain the dedifferentiated state (Ge, Fu, & Meadows, 2002; Smalley & Eisen, 2000; Smalley, 2003; Smalley & Eisen, 2002) . These pathways include MAPK signaling, integrin signaling, PI3K signaling, STAT5 signaling, and repression of immune response (Delfgaauw et al., 2003; Geissinger, Weisser, Fischer, Schartl, & Wellbrock, 2002; Morcinek, Weisser, Geissinger, Schartl, & Wellbrock, 2002; Schartl et al., 2015; Wellbrock et al., 2002) . Although some of the direct functions of xmrk-driven pathways are well studied, a comprehensive understanding of genes and functional pathways that are associated with xmrk-induced dedifferentiation is lacking. As a continuation of previous studies, we used xmrk expression as a marker and utilized contemporary RNASeq to perform global assessment of molecular genetic profiles in these Xiphophorus melanoma to hallmark genes that co-express or are reversely correlated with xmrk, to identify pathways that are associated with xmrk expression. We compare functional pathways associated with differentiated pigmentation-related gene expression, a feature characterizing terminally differentiated pigment cells in human melanoma patients, to the functional pathways that are associated with genes that are co-expressed with xmrk in Xiphophorus melanoma. This strategy allowed identification of gene clusters representing the dedifferentiated status of Xiphophorus melanoma and may be related to the invasive capacity of the melanoma cells.
The similarity in functional pathways between the Xiphophorus melanoma and human melanoma suggests that melanomagenesis in Xiphophorus is an informative genetic representation of human melanoma etiology.
Significance
Our observation that the transcriptomic feature of Xiphophorus melanoma represents dedifferentiated, proliferative human melanoma suggests that Xiphophorus melanoma model is an appropriate model system of human melanoma, enabling application of melanoma etiological discovery among vertebrates. Additionally, delineating the mechanism of xmrk-driven melanomagenesis and identifying compounds that are able to repressing the xmrk-initiated transcriptional changes may be applicable to human melanoma treatment.
| RESULTS

| Identification of an xmrk co-expression signature in Xiphophorus melanoma
The backcross of F 1 hybrid (Sd-hellerii) and X. hellerii leads to spontaneous melanoma in 25% of the BC 1 and BC 5 progeny (Figure 1 ). These tumors expand from the dorsal fin and/or caudal fin and peduncle of the interspecies hybrid progeny. To profile global gene expression, we performed RNA-Seq and assessed gene expression of these melanomas ( Figure S1 ). High expression of the driver oncogene, xmrk, is capable of inducing spontaneous melanoma (Schartl et al., 2010; Wittbrodt et al., 1989) . The expression of the xmrk in pigment cell both suppresses differentiation and induces a transformed dedifferentiated phenotype . However, xmrk gene expression levels vary among melanomas by 9.6-fold in both BC 1 and BC 5 interspecies hybrid progeny Table S2 ). Nine stem cell/melanoma cancer stem cell marker, cfl, itga6, itga8, itgb1, tbx2, cdh7, cdh20 , and zeb1 are co-expressed with xmrk in the Xiphophorus melanoma (Figure 2c,d ). This is in agreement with previous reports showing that xmrk is capable of dedifferentiating melanocytes in this model system (Delfgaauw et al., 2003; Wellbrock et al., 2002) .
| Differential gene expression between high-and low-MITF-axis melanoma patient cohorts
Compared to terminally differentiated melanoma cells, invasive melanoma cells are characterized by the loss of pigmentationrelated genes, amelanotic and dedifferentiated phenotypes (Delfgaauw et al., 2003; Dotto et al., 1989; Wellbrock et al., 2002; Wilson et al., 1989) . To identify genes that are coregulated with pigmentation-related genes, we next assessed the gene expression differences between melanoma patient cohorts exhibiting differentiated pigmentation pathway activities.
Terminally differentiated melanoma cells show higher expression of melanin biosynthesis genes than dedifferentiated melanoma cells, and this feature was used to identify genes that are re- 
| Comparison of functional pathways between Xiphophorus melanoma and human melanoma
As both the xmrk co-expressed genes, and the low-MITF-axis cohort shows dedifferentiation markers, we next attempted to identify functional pathways that are associated with the observed gene expression signature that may represent dedifferentiation. The xmrk co-expressed genes, and genes that show negative correlation to the xmrk expression pattern, were analyzed using gene set enrich- Table S4 ). Similarly, pathway enrichment analysis was also performed on differentially expressed genes between the two melanoma patient cohorts. These genes were clustered into 29 functional pathways (−log 10 (enrichment p-value) > 2; Figure 4a,c; Table S4 ). Twelve signaling pathways F I G U R E 3 Differential gene expression in human melanoma (a) To identify human melanoma patient samples with high MITF and MITF target genes, samples were categorized based on MITF, TYR, TYRP1, and DCT expression. Samples with each individual gene expressed higher than 50% of all patient samples were classified as high-MITF-axis cohort, while samples with each MITF target gene expressed lower than 50% of all patient samples were classified as low-MITF-axis cohort. Differential gene expression between these two cohorts of melanoma patients showed 491 genes to be differentially expressed (|log2FC| ≥ 1, FDR < 0.05, AUC ≥ 0.8). (b) In addition to MITF, TYR, TYRP1, and DCT, 17 other pigmentation-related genes were also higher expressed in patients that over-expressed MITF and its target genes. Thirteen dedifferentiation-related genes showed lower expression and two differentiation-related genes showed higher expression in high-MITF-axis cohort [Colour figure can be viewed at wileyonlinelibrary.com] (axonal guidance signaling, colorectal cancer metastasis signaling, epithelial adherence junction signaling, eumelanin biosynthesis, IL8 signaling, ILK signaling, melanocyte development and pigmentation signaling, molecular mechanism of cancer, ovarian cancer signaling, pancreatic adenocarcinoma signaling, semaphorin signaling in neurons, and superpathway of inositol phosphate compounds) are shared between the Xiphophorus melanoma and human melanoma (Figure 4a,b) . Three of the 12 shared pathways (colorectal cancer metastasis signaling, IL-8 signaling, and pancreatic adenocarcinoma signaling) are repressed in the patient cohorts that highly express pigmentation-related genes and activated in the patient cohorts that lowly express pigmentation-related genes. The same 3 pathways are activated in the Xiphophorus melanoma with highly expressed xmrk and its co-expressed genes (Table S4) .
| DISCUSSION
The xmrk oncogene is a mutant copy of fish egfr gene encoding a receptor tyrosine kinase that forms constitutively homodimers and thereby becomes activated in a ligand-independent manner. Although (Delfgaauw et al., 2003; Wellbrock et al., 1998 Wellbrock et al., , 2002 . It has been shown to repress the MITF differentiation signal, implying MITF functional suppression partially accounts for the mechanism by which xmrk drives dedifferentiation (Delfgaauw et al., 2003) . We found that xmrk expression varied in the Xiphophorus melanoma (Figure 2a Figure   S4b ; Table S4 ; Meierjohann et al., 2004; Schartl et al., 2015; Wellbrock & Schartl, 2000; Wellbrock et al., 2002) .
As the expression of MITF driven pigmentation-related genes and melanogenesis hallmarks the differentiated status of pigment cells, we used MITF and its target genes related to pigment synthesis TYR, TYRP, and DCT to represent different transcriptomic features of disease subtypes in human melanoma (i.e., dedifferentiation and differentiation; Carreira et al., 2005 Carreira et al., , 2006 Cheli et al., 2011 Cheli et al., , 2012 Cheli, Ohanna, Ballotti, & Bertolotto, 2010; Garraway et al., 2005; Hoek & Goding, 2010; Loercher, Tank, Delston, & Harbour, 2005; Pinner et al., 2009 ).
As expected, we identified two melanoma patient sample cohorts: a cohort that lowly expressed melanin synthesis genes (low-MITF-axis), and a cohort that highly expressed melanin synthesis genes (high-
MITF-axis).
Along with the lower expression of pigmentation-related genes, the low-MITF-axis cohort shows higher expression of stem cell, neural crest progenitor cell, and melanoma cells dedifferentiation markers LIF, NGFR (CD271), and NFATC2 (Figure 3b ; Bernhardt et al., 2017; Boiko et al., 2010; Landsberg et al., 2012; Martello & Smith, 2014; Perotti et al., 2016; Riesenberg et al., 2015) . Their higher expression suggested that melanomas in low-MITF-axis cohort have a higher percentage of dedifferentiated melanoma cells. Low-MITFaxis cohort also highly expresses S100A4, a metastasis-promoting microenvironment factor (Berge et al., 2011; Schmidt-Hansen et al., 2004) , as well as several dedifferentiation-related metabolism genes
MT1X, MT1A, MT2A, NNMT, NT5E, MT1G, AKR1C1, AKR1C2, GLDC.
Additionally, low-MITF-axis cohort lowly expresses differentiationrelated metabolism genes PPARGC1 and GYG2 (Bettum et al., 2015) .
These observations suggest the low-MITF-axis cohort represents dedifferentiated melanoma tumors that are characterized by stem cell-like transcriptional features, while the high-MITF-axis cohort is associated with differentiated non-invasive melanoma (Figure 3b ).
Genes coregulated with MITF and its target genes in human melanoma are mainly related to expected pigmentation, inflammation, cell migration and proliferation, cancer development and metastasis, and stem cell ( Figure S4c ; Table S4 ). The presence of these signaling pathways is consistent with the dedifferentiation status of low-MITF-axis melanoma cohort, suggesting the low expression of MITF and its target genes is indicative of the dedifferentiation expression signature and the phenotype of a subtype of melanoma cells.
To test whether the dedifferentiation of Xiphophorus melanoma and human melanoma involved similar signaling pathways, we next compared the functional pathways associated with genes that were co-expressed with xmrk in Xiphophorus melanoma to pathways associated with genes that were differentially expressed between the high-and low-MITF-cohort. We found 12 functional pathways that are shared between Xiphophorus melanoma and human melanoma (Figure 4a,b) . These pathways involved in inflammation (IL-8 signaling), cell migration (axonal guidance signaling, epithelial adherence junction signaling, ILK signaling, semaphorin signaling, superpathway of inositol phosphate compounds), pigmentation (eumelanin biosynthesis, melanocyte development and pigmentation signaling), proliferation, cancer development, and metastasis (colorectal cancer metastasis signaling, ovarian cancer signaling, pancreatic adenocarcinoma signaling, molecular mechanism of cancer). To summarize, the genetic signature comparisons between Xiphophorus and human melanoma correspond to very similar groups of functional pathways and suggest that all vertebrate melanomas may share disease-specific genetic signatures reflecting common developmental mechanisms ( Figure 5 ).
Additionally, IL8 signaling and two signaling pathways related to cancer metastasis (colorectal cancer metastasis signaling and pancreatic adenocarcinoma signaling) are activated by xmrk co-expressed genes.
The same pathways are also activated in melanoma cohorts that lowly expressed pigmentation-related genes (Table S4 ). This consistency in functional changes indicates the high expressing xmrk Xiphophorus melanoma share transcriptomic features, and molecular functions of highly proliferative, dedifferentiated human melanoma. These results further substantiate the Xiphophorus melanoma model as representing melanoma cancer cell plasticity at the genetic level, and its potential utility as a model to delineate the genetic etiology of select states in melanoma progression.
In conclusion, the transcriptomic features and tumorigenic pathways related to the xmrk expression faithfully represent the genetic differences between non-proliferative differentiated and mitogenic dedifferentiated human melanoma. This property supports Xiphophorus melanoma as an appropriate disease model of human melanoma, enabling application of melanoma etiological discovery among vertebrates. Additionally, delineating the mechanism of xmrk-driven melanomagenesis and identifying compounds that are able to repressing the xmrk-initiated transcriptional changes that may be applicable to human melanoma treatment. 
| METHODS
| Animal model
| RNA isolation and RNA sequencing
RNA from a total of 16 melanoma tumors and skin dissected from BC 1 interspecies hybrid progeny, as well as 13 BC 5 melanoma tumors, was isolated as previously detailed (Lu et al., 2015; Walter et al., 2014) using TRI reagent (Sigma Inc.). Briefly, samples were homogenized in TRI reagent followed by addition of 200 μl/ml chloroform and the samples vigorously shaken and subjected to centrifugation at 12,000 g for 15 min at 4°C. Total RNA was further purified using RNeasy mini RNA isolation kit (Qiagen, Valencia, CA, USA). Residual DNA was eliminated by incubating RNA samples with DNase for DNA digestion at 25°C for 15 min. Total RNA concentration was determined using a Qubit 2.0 fluorometer (Life Technologies, Grand Island, NY, USA). RNA quality was verified on an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) to confirm that RIN scores were above 8.0 prior to sequencing.
RNA sequencing of BC 1 fish was performed upon libraries constructed using the Illumina TruSeq library preparation system (Illumina, Inc., San Diego, CA, USA). RNA libraries were sequenced as 125-bp paired-end fragments using Illumina Hi-Seq 2000 system (Illumina, Inc.). RNA libraries of BC 5 fish were sequenced as 100-bp paired-end fragments using the Illumina Hi-Seq 4000 system (Illumina, Inc.) by the Beijing Genomics Institute (BGI, Hong Kong, China). Sequencing adaptors were removed from raw sequencing reads. The processed reads were subsequently trimmed and filtered based on quality scores using a custom filtration algorithm that removed low-scoring sections of each read and preserved the longest remaining fragment (Garcia et al., 2012) . For RNA-Seq statistics, see Table S1 . Schartl et al., 2013; Shen et al., 2016; Wittbrodt et al., 1989) . The trimmed and filtered short sequencing reads were aligned to the custom transcriptome using Bowtie2 (Langmead & Salzberg, 2012) . Custom Perl scripts were developed to count short sequencing reads with either a perfect alignment to one transcript or a perfect secondary alignment to include all short reads mapped to both X. maculatus and X. hellerii alleles of a given gene (Lu et al., 2015; Shen et al., 2013) . Sequencing read counts of each gene were normalized to the corresponding library size. BC 1 and BC 5 melanomas were ranked on their xmrk expression, respectively. A gene expression correlation coefficient was calculated for each coding gene using Spearman ranking correlation analysis. A gene with correlation coefficient ≥ .5 or ≤−.5 was classified as xmrk co-expressed gene or xmrk negative correlated gene. Only genes that showed co-expression or negative correlation with xmrk in both BC 1 and BC 5 melanoma are further analyzed. The workflow of sample collection and data processing is given in Figure S1 .
| Gene expression profiling and co-expression analysis in Xiphophorus melanoma model
| Differential gene expression analysis in human melanoma
A total of 473 gene expression profiles from human skin cutaneous melanoma (SKCM) were retrieved from The Cancer Genome Atlas (TCGA, tcga-data.nci.nih.gov) SKCM dataset through TCGA data portal. A custom perl script was used to combine the dataset and append a patient-specific sample name to corresponding expression profiles. To separate tumor samples with high pigmentation pathway gene expression and low pigmentation pathway gene expression, tumor samples were ranked on expression levels of MITF, TYR, TYRP1, and DCT. Tumor samples with these four genes expressed in lower than 50% of all samples were classified as low pigmentation pathway activity samples (low-MITF-axis cohort). Tumor samples with these four genes expressed in higher than 50% of all samples were classified as high pigmentation pathway activity samples Differential gene expression analyses were performed between high and low pigmentation pathway activity samples using edgeR (log 2 FC ≥ 1 or log 2 FC ≤ −1, FDR ≤ 0.05; (Robinson, McCarthy, & Smyth, 2010) . To identify the most diagnostic differentially expressed genes in human SKCM dataset, a receiver operating characteristic (ROC) curve was plotted for each differentially expressed gene using R/Bioconductor package pROC. Only differentially expressed genes with ROC area under curve (AUC) ≥ 0.8 were kept for further analysis.
| Gene set enrichment analysis
Gene ontology (GO) analysis was conducted using R package "GOstats" (Falcon & Gentleman, 2007) . All genes with designated GO term in the GO database (GO.db) were used as background genes, and an enrichment p-value of .001 was used to determine statistically significant enrichment. Pathway analysis of xmrk coregulated genes in the Xiphophorus melanoma and differentially expressed genes in human melanoma was conducted by implementing Ingenuity Pathway Analysis (IPA, Qiagen, Redwood City, CA, USA).
Pathway enrichment was determined by a p-value < .01 (or −log 10 pvalue > 2). Signaling pathways that share genes are connected to form functional network using R package "igraph." Node size represents number of genes belonging to certain pathways. Width of edges represents number of shared genes of connected pathways.
Functional networks were formed using a force-directed layout algorithm.
| Quantitative real-time PCR
Xiphophorus melanoma-derived gene expression was compared to paired normal skin for identification of differential gene expression (log 2 FC ≥ 1 or log 2 FC ≤ −1, FDR ≤ 0.05, log 2 CPM ≥ 1). A total of 2,044 genes differentially expressed (1,057 genes downregulated, 987 genes upregulated) between BC 1 tumors and paired normal skin tissue. Ten genes were chosen to be validated using QRT-PCR. QRT-PCR was performed by SYBR Green-based detection with an Applied Biosystems 7500Fast system (Applied Bioscience, Carlsbad, CA, USA).
Each reaction was subjected to 40 cycles each at 95°C for 20 s, 95°C for 15 s, and 60°C for 30 s. The 18S gene was selected for normalization of all samples. The mean CT values from triplicate runs were used to calculate relative expression levels between tumors and paired skin samples ( Figure S3 ).
